BioLife Solutions, Inc. (BLFS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1151225,
    "name": "BioLife Solutions, Inc.",
    "stock_name": "BioLife Solutions, Inc.",
    "full_name": "BioLife Solutions, Inc.",
    "name_url": "stocks-analysis/biolife-solutions-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "25.83",
    "chg": 0.46,
    "chgp": "1.81%",
    "dir": 1,
    "prev_price": "25.37",
    "mcapval": "1,256.08",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US09062W2044",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "627.7 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biolife-solutions-inc-1151225-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "BioLife Solutions Hits New 52-Week High at $29.62, Up 33.78%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biolife-solutions-hits-new-52-week-high-at-2962-up-3378-3649178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BioLifeSolution_priceRelatedfactors_3649178.png",
        "date": "2025-10-27 16:37:20",
        "description": "BioLife Solutions, Inc. achieved a new 52-week high of USD 29.62 on October 24, 2025, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a significant increase over the past year, outperforming the S&P 500, despite being loss-making and having no dividend yield."
      },
      {
        "title": "BioLife Solutions, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biolife-solutions-inc-technical-trend-shifts-from-sideways-to-bullish-amid-recent-performance-gains-3600885",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BioLifeSolution_technicaldot_3600885.png",
        "date": "2025-10-07 19:24:30",
        "description": "BioLife Solutions, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock, priced at $26.52, has experienced notable volatility over the past year. Technical indicators suggest a generally positive outlook, while performance comparisons with the S&P 500 reveal mixed results over different time frames."
      },
      {
        "title": "BioLife Solutions Forms Golden Cross, Signaling Potential Bullish Breakout Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biolife-solutions-forms-golden-cross-signaling-potential-bullish-breakout-ahead-3595209",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BioLifeSolution_goldencross_3595209.png",
        "date": "2025-10-06 15:16:17",
        "description": "BioLife Solutions, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock outperformed the S&P 500 today and over the past week, with various technical indicators showing bullish signals. This activity suggests growing interest and confidence in the company’s prospects."
      },
      {
        "title": "Is BioLife Solutions, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-biolife-solutions-inc-technically-bullish-or-bearish-3593460",
        "imagepath": "",
        "date": "2025-10-06 11:58:48",
        "description": "As of 3 October 2025, the technical trend for BioLife Solutions, Inc. has changed from sideways to bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also indicate a bullish stance across both time frames. Daily moving averages confirm a bullish trend. However, the KST is bullish on a weekly basis but mildly bearish monthly, while the Dow Theory shows a mildly bearish signal weekly with no trend monthly. The OBV is mildly bearish weekly and shows no trend monthly. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 7.65% and 6.19% respectively, but lags behind the index on a year-to-date and yearly basis. Overall, the current technical stance is bullish, albeit with some mixed signals in the longer-term indicators...."
      },
      {
        "title": "Is BioLife Solutions, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-biolife-solutions-inc-technically-bullish-or-bearish-3591533",
        "imagepath": "",
        "date": "2025-10-05 11:43:38",
        "description": "As of 3 October 2025, the technical trend for BioLife Solutions, Inc. has changed from sideways to bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also indicate a bullish stance across both time frames. The daily moving averages are bullish as well. However, the KST shows a mildly bearish trend on the weekly and a no trend on the monthly, while Dow Theory indicates a mildly bearish stance weekly and no trend monthly. The On-Balance Volume is mildly bearish weekly and shows no trend monthly.\n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 7.65% and 6.19% respectively, while the S&P 500 returned 1.09% and 4.15%. However, over longer periods, the stock has underperformed the S&P 500, particularly in the 3-year and 5-year comparisons.\n\nOverall, the current technical stance is bullish, but with some mixed signals indicating..."
      },
      {
        "title": "Is BioLife Solutions, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-biolife-solutions-inc-technically-bullish-or-bearish-3545109",
        "imagepath": "",
        "date": "2025-09-20 19:03:52",
        "description": "As of 10 September 2025, the technical trend for BioLife Solutions, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. Bollinger Bands are bullish for both weekly and monthly periods, supporting the mildly bullish stance. The Dow Theory also reflects a mildly bullish outlook on both weekly and monthly bases. However, the daily moving averages are mildly bearish, which adds some caution. \n\nIn terms of performance, the stock has underperformed the S&P 500 over the year and the last three years, with returns of 10.79% and 13.67% respectively, compared to the S&P 500's 17.14% and 70.41%. Overall, the current technical stance is mildly bullish, driven by strong weekly indicators, despite some bearish signals in the daily moving averages...."
      },
      {
        "title": "Is BioLife Solutions, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-biolife-solutions-inc-overvalued-or-undervalued-3541829",
        "imagepath": "",
        "date": "2025-09-20 17:37:20",
        "description": "As of 28 February 2022, the valuation grade for BioLife Solutions, Inc. moved from fair to risky, indicating a shift towards a more negative outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 3.20 and an EV to Capital Employed ratio of 3.78, which suggest that the market is pricing the company at a premium despite its losses. Additionally, the negative EV to EBIT and EV to EBITDA ratios of -137.15 and -1053.88 respectively highlight significant operational challenges.\n\nIn comparison to peers, BioLife Solutions has a P/E ratio of -62.83, while Artivion, Inc. shows a much larger negative P/E of -268.22, and Embecta Corp. stands out with a positive P/E of 6.42, indicating that BioLife is struggling more than its peers. The company's stock has underperformed against the S&P 500 over multiple periods, notably with a 3-year return of 13.67% compared..."
      }
    ],
    "total": 12,
    "sid": "1151225",
    "stock_news_url": "https://www.marketsmojo.com/news/biolife-solutions-inc-1151225"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

BioLife Solutions Hits New 52-Week High at $29.62, Up 33.78%

2025-10-27 16:37:20

BioLife Solutions, Inc. achieved a new 52-week high of USD 29.62 on October 24, 2025, reflecting its strong performance in the Pharmaceuticals & Biotechnology sector. The company has seen a significant increase over the past year, outperforming the S&P 500, despite being loss-making and having no dividend yield.

BioLife Solutions, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-10-07 19:24:30

BioLife Solutions, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock, priced at $26.52, has experienced notable volatility over the past year. Technical indicators suggest a generally positive outlook, while performance comparisons with the S&P 500 reveal mixed results over different time frames.

BioLife Solutions Forms Golden Cross, Signaling Potential Bullish Breakout Ahead

2025-10-06 15:16:17

BioLife Solutions, Inc. has recently achieved a Golden Cross, indicating a potential shift in momentum. The stock outperformed the S&P 500 today and over the past week, with various technical indicators showing bullish signals. This activity suggests growing interest and confidence in the company’s prospects.

Is BioLife Solutions, Inc. technically bullish or bearish?

2025-10-06 11:58:48

As of 3 October 2025, the technical trend for BioLife Solutions, Inc. has changed from sideways to bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also indicate a bullish stance across both time frames. Daily moving averages confirm a bullish trend. However, the KST is bullish on a weekly basis but mildly bearish monthly, while the Dow Theory shows a mildly bearish signal weekly with no trend monthly. The OBV is mildly bearish weekly and shows no trend monthly. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 7.65% and 6.19% respectively, but lags behind the index on a year-to-date and yearly basis. Overall, the current technical stance is bullish, albeit with some mixed signals in the longer-term indicators....

Is BioLife Solutions, Inc. technically bullish or bearish?

2025-10-05 11:43:38

As of 3 October 2025, the technical trend for BioLife Solutions, Inc. has changed from sideways to bullish. The weekly and monthly MACD indicators are bullish, and Bollinger Bands also indicate a bullish stance across both time frames. The daily moving averages are bullish as well. However, the KST shows a mildly bearish trend on the weekly and a no trend on the monthly, while Dow Theory indicates a mildly bearish stance weekly and no trend monthly. The On-Balance Volume is mildly bearish weekly and shows no trend monthly. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, returning 7.65% and 6.19% respectively, while the S&P 500 returned 1.09% and 4.15%. However, over longer periods, the stock has underperformed the S&P 500, particularly in the 3-year and 5-year comparisons. Overall, the current technical stance is bullish, but with some mixed signals indicating...

Is BioLife Solutions, Inc. technically bullish or bearish?

2025-09-20 19:03:52

As of 10 September 2025, the technical trend for BioLife Solutions, Inc. has changed from sideways to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bearish, indicating mixed signals across time frames. Bollinger Bands are bullish for both weekly and monthly periods, supporting the mildly bullish stance. The Dow Theory also reflects a mildly bullish outlook on both weekly and monthly bases. However, the daily moving averages are mildly bearish, which adds some caution. In terms of performance, the stock has underperformed the S&P 500 over the year and the last three years, with returns of 10.79% and 13.67% respectively, compared to the S&P 500's 17.14% and 70.41%. Overall, the current technical stance is mildly bullish, driven by strong weekly indicators, despite some bearish signals in the daily moving averages....

Is BioLife Solutions, Inc. overvalued or undervalued?

2025-09-20 17:37:20

As of 28 February 2022, the valuation grade for BioLife Solutions, Inc. moved from fair to risky, indicating a shift towards a more negative outlook. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 3.20 and an EV to Capital Employed ratio of 3.78, which suggest that the market is pricing the company at a premium despite its losses. Additionally, the negative EV to EBIT and EV to EBITDA ratios of -137.15 and -1053.88 respectively highlight significant operational challenges. In comparison to peers, BioLife Solutions has a P/E ratio of -62.83, while Artivion, Inc. shows a much larger negative P/E of -268.22, and Embecta Corp. stands out with a positive P/E of 6.42, indicating that BioLife is struggling more than its peers. The company's stock has underperformed against the S&P 500 over multiple periods, notably with a 3-year return of 13.67% compared...

View All News